News | Advanced Visualization | October 20, 2017

Analytics 4 Life Raises $25 Million for AI-Backed Cardiac Imaging Technology

Funding will advance proprietary imaging technology designed to assess coronary artery disease with a machine learning algorithm

Analytics 4 Life Raises $25 Million for AI-Backed Cardiac Imaging Technology

October 20, 2017 — Digital health company Analytics 4 Life announced it has completed a $25 million Series B financing. This financing event was supported by an international syndicate of accredited investors, including physicians, healthcare professionals and medical device experts. The company's novel cardiac imaging technology is under clinical investigation to help physicians assess the presence of coronary artery disease (CAD) using intrinsic signals scanned from the body without radiation, contrast agents or cardiac stress.

Current diagnostic methods for CAD are costly, risky and time-consuming. Analytics 4 Life seeks to address these challenges with its novel method of cardiac imaging. The company's technology represents a new approach to cardiac imaging based on advanced disciplines of mathematics and physics combined with the power of cloud computing and artificial intelligence. The first application of this technology is CorVista, a non-invasive, physician-directed diagnostic test that aims to identify the presence of CAD without radiation or cardiac stress.

CorVista is designed to scan signals naturally emitted by the body with a synchronous array of seven sensors on Analytics 4 Life's proprietary collection device. After the signals are acquired, the signal package is instantaneously transmitted to the cloud where it is analyzed by a machine-learned algorithm to generate a unique image and a heart model indicating areas of potential heart disease associated with the presence of CAD. The results of the test are displayed on a secure physician web portal that, in combination with a patient's medical history, risk factors and symptoms, are used by the interpreting physician to recommend further treatment.

A two-stage clinical trial at 13 sites in the United States is currently underway to support CorVista's development and regulatory filings. The ongoing study, with more than 2,000 patients enrolled so far, will measure the performance of a machine-learned algorithm for CAD detection to gold-standard cardiac catheterization results.  

Preliminary results will be presented at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference, Oct. 29-Nov. 2 in Denver. Assuming a positive U.S. Food and Drug Administration (FDA) review, the company anticipates having CorVista available in the U.S. next year.

For more information: www.analytics4life.com

Related Content

Technological Advancements Expected to Drive Virtual Reality Growth in Healthcare
News | Advanced Visualization | April 04, 2019
Increasing demand for innovative diagnostic techniques, neurological disorders and increasing disease awareness are...
Medivis Unveils AnatomyX Augmented Reality Education Platform
Technology | Advanced Visualization | April 02, 2019
Medical imaging and visualization company Medivis announced the launch of AnatomyX, its augmented reality (AR) platform...
DrChrono and 3D4Medical Partner to Bring 3-D Interactive Modeling to Physician Practices
News | Advanced Visualization | March 18, 2019
DrChrono Inc. and 3D4Medical have teamed up so practices across the United States can access 3-D interactive modeling...
Videos | Advanced Visualization | March 05, 2019
Augmented reality (AR) and virtual reality (VR) are starting to be adopted for physician training, patient education
Philips Introduces IntelliSpace Portal 11 at ECR 2019
Technology | Advanced Visualization | February 27, 2019
Philips announced the launch of IntelliSpace Portal 11, the latest release of the company’s comprehensive, advanced...
Philips and Microsoft have partnered to develop an augmented reality system to help imporve workflow and procedural navigation in the cath lab. Physicians wearing visors can view and interact with true 3-D holograms above the patient on the table and manipulate the image with voice and hand motion commands to avoid breaking the sterile field. Virtual reality in the cath lab, interventional lab, hybrid OR, or cardiovascular lab.

Philips and Microsoft have partnered to develop an augmented reality system to help imporve workflow and procedural navigation in the cath lab. Physicians wearing visors can view and interact with true 3-D holograms above the patient on the table and manipulate the image with voice and hand motion commands to avoid breaking the sterile field. 

News | Advanced Visualization | February 25, 2019
Philips will unveil a new mixed reality concept developed together with Microsoft that the company says is designed for...
Medivis Launches SurgicalAR Augmented Reality Platform
Technology | Advanced Visualization | February 14, 2019
Medical imaging and visualization company Medivis officially unveiled SurgicalAR, its augmented reality (AR) technology...
Videos | Advanced Visualization | December 12, 2018
This is an example of the FDA-cleared OpenSight augmented reality (AR) system for surgical planning from NovaRad at t
Nihon Kohden Launches Augmented Reality Electrophysiology Training App at HIMSS18
Technology | Advanced Visualization | March 06, 2018
Nihon Kohden announced the launch of the Nihon Kohden Dimensions Augmented Reality (AR) App to complement the Clinical...
NIH Issues $2.2 Million Grant for Augmented Reality Cardiac Hologram Research
News | Advanced Visualization | February 15, 2018
February 15, 2018 — The National Institutes of Health (NIH) awarded a $2.2 million research grant to healthcare techn
Overlay Init